Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Teva Pharmaceutical Industries ADR (TEVA)

Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Teva Pharmaceutical Industries ADR 124 DVORA HANEVI'a STREET TEL AVIV L3 6944020 ISR

www.tevapharm.com Employees: 33,950 P: 972-3914-8213

Sector:

Medical

Description:

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.

Key Statistics

Overview:

Market Capitalization, $K 39,421,012
Enterprise Value, $K 52,671,012
Shares Outstanding, K 1,146,960
Float, K 1,141,340
% Float 99.51%
Short Interest, K 32,969
Short Float 2.87%
Days to Cover 2.90
Short Volume Ratio 0.42
% of Insider Shareholders 0.49%
% of Institutional Shareholders 54.05%

Financials:

Annual Sales, $ 17,258 M
Annual Net Income, $ 1,411 M
Last Quarter Sales, $ 4,711 M
Last Quarter Net Income, $ 481,000 K
EBIT, $ 2,417 M
EBITDA, $ 3,419 M

Growth:

1-Year Return 106.90%
3-Year Return 241.65%
5-Year Return 211.32%
5-Year Revenue Growth 3.60%
5-Year Earnings Growth 15.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.96 on 01/28/26
Next Earnings Date 05/06/26
Earnings Per Share ttm 2.81
EPS Growth vs. Prev Qtr 24.00%
EPS Growth vs. Prev Year 32.86%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.072 on 11/27/17
Next Ex-Dividends Date 11/27/17
Dividend Payable Date 03/03/15
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 07/01/04

TEVA Ratios

Ratio
Price/Earnings ttm 12.27
Price/Earnings forward 13.04
Price/Earnings to Growth 1.96
Return-on-Equity % 46.28%
Return-on-Assets % 8.22%
Profit Margin % 8.18%
Debt/Equity 2.12
Price/Sales 2.29
Price/Cash Flow 9.22
Price/Book 5.00
Book Value/Share 6.90
Interest Coverage -1.22
60-Month Beta 0.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar